2024 annual financial data
Mineralys Therapeutics 2024 Operating margin
Mineralys Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -192,403,000 USD and net income was -177,810,000 USD.
Operating cash flow was -166,314,000 USD.
Get free Mineralys Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -192,403,000 USD
- Net income
- -177,810,000 USD
- Operating cash flow
- -166,314,000 USD